Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Sands

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Nature Communications|June 13, 2023
Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetesJisu Oh, Amy E Riek, Kevin T Bauerle, et al.
Cell Stem Cell|May 1, 2012
Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cellsMargaret A Young, David E Larson, Chiao-Wang Sun, et al.
Science Translational Medicine|January 15, 2025
Gene therapy ameliorates bowel dysmotility and enteric neuron degeneration and extends survival in lysosomal storage disorder mouse modelsEwa A Ziółkowska, Matthew J Jansen, Letitia L Williams, et al.
Journal of Medical Genetics|February 25, 2016
Clinical course of sly syndrome (mucopolysaccharidosis type VII)Adriana M Montaño, Ngu Lock-Hock, Robert D Steiner, et al.
The Journal of Clinical Investigation|August 30, 2022
Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheepHemanth R Nelvagal, Samantha L Eaton, Sophie H Wang, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Nature Communications|June 13, 2023
Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetesJisu Oh, Amy E Riek, Kevin T Bauerle, et al.
Cell Stem Cell|May 1, 2012
Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cellsMargaret A Young, David E Larson, Chiao-Wang Sun, et al.
Science Translational Medicine|January 15, 2025
Gene therapy ameliorates bowel dysmotility and enteric neuron degeneration and extends survival in lysosomal storage disorder mouse modelsEwa A Ziółkowska, Matthew J Jansen, Letitia L Williams, et al.
Journal of Medical Genetics|February 25, 2016
Clinical course of sly syndrome (mucopolysaccharidosis type VII)Adriana M Montaño, Ngu Lock-Hock, Robert D Steiner, et al.
The Journal of Clinical Investigation|August 30, 2022
Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheepHemanth R Nelvagal, Samantha L Eaton, Sophie H Wang, et al.
Pageof 11